Key result
Abnormal baseline carotid IMT was present in 67.2% of males and 50.8% of females, with progression over 2 years significantly associated with LDL-C in males and HDL-C in females.
Cohort (n=171)
In patients with newly diagnosed type 2 diabetes, LDL-C in males and HDL-C in females are significant risk factors for the progression of carotid intima-media thickness over 2 years.
Sex-specific lipid associations with IMT progression in new T2D support monitoring; hypothesis-generating for targeted trials.
BACKGROUND: Intima-media thickness (IMT) of the carotid arteries is known to have a positive correlation with the risk of cardiovascular disease. This study was designed to identify risk factors affecting the progression of carotid IMT in patients with type 2 diabetes mellitus (T2DM). METHODS: Patients with newly diagnosed T2DM with carotid IMT measurements were enrolled, and their clinical data and carotid IMT results at baseline and 2 years later were compared. RESULTS: Of the 171 patients, 67.2% of males and 50.8% of females had abnormal baseline IMT of the left common carotid artery. At baseline, systolic blood pressure, body mass index and smoking in male participants, and fasting plasma glucose and glycated hemoglobin levels in females were significantly higher in patients with abnormal IMT than in those with normal IMT. Low density lipoprotein cholesterol (LDL-C) levels in males and high density lipoprotein cholesterol (HDL-C) levels in females at the 2-year follow-up were significantly different between the nonprogression and the progression groups. Reduction of the United Kingdom Prospective Diabetes Study (UKPDS) 10-year coronary heart disease (CHD) risk score after 2 years was generally higher in the nonprogression group than the progression group. CONCLUSION: LDL-C levels in males and HDL-C levels in females at the 2-year follow-up were significantly different between participants with and without progression of carotid IMT. Furthermore, a reduction in the UKPDS 10-year CHD risk score appeared to delay the advancement of atherosclerosis. Therefore, the importance of establishing the therapeutic goal of lipid profiles should be emphasized to prevent the progression of carotid IMT in newly diagnosed T2DM patients.
No takes yet. Share an insight, caveat, or question.
Chin et al. (2013) conducted a cohort in Type 2 diabetes mellitus (n=171). Risk factors (lipid profiles, UKPDS score) was evaluated on Progression of carotid IMT. Abnormal baseline carotid IMT was present in 67.2% of males and 50.8% of females, with progression over 2 years significantly associated with LDL-C in males and HDL-C in females.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: